These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8639259)

  • 41. Ultrasound and cholangiography for the diagnosis of biliary complications after orthotopic liver transplantation: a comparative study.
    Kok T; Van der Sluis A; Klein JP; Van der Jagt EJ; Peeters PM; Slooff MJ; Bijleveld CM; Haagsma EB
    J Clin Ultrasound; 1996; 24(3):103-15. PubMed ID: 8838298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Delayed biliary duct obstruction after orthotopic liver transplantation.
    Martineau G; Porter KA; Corman J; Launois B; Schroter GT; Palmer W; Putnam CW; Groth CG; Halgrimson CG; Penn I; Starzl TE
    Surgery; 1972 Oct; 72(4):604-10. PubMed ID: 4341571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of cytomegalovirus infection on long-term survival after orthotopic liver transplantation.
    Hoppe L; Marroni CA; Bressane R; Lago L; Schiavo FL; Cigerza GC; Brandão AB; Zanotelli ML; Cantisani GP
    Transplant Proc; 2006; 38(6):1924-5. PubMed ID: 16908325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
    Jain A; Orloff M; Kashyap R; Lansing K; Betts R; Mohanka R; Menegus M; Ryan C; Bozorgzadeh A
    Transplant Proc; 2005 Sep; 37(7):3182-6. PubMed ID: 16213344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biliary complications following liver transplantation in the model for end-stage liver disease era: effect of donor, recipient, and technical factors.
    Welling TH; Heidt DG; Englesbe MJ; Magee JC; Sung RS; Campbell DA; Punch JD; Pelletier SJ
    Liver Transpl; 2008 Jan; 14(1):73-80. PubMed ID: 18161843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polyoma virus-associated nephropathy and concurrent cytomegalovirus infection in the kidney transplant recipients.
    Park SB; Kwak JH; Lee KT; Hwang EA; Han SY; Kim HT; Cho WH; Choi MS; Kim HC
    Transplant Proc; 2006 Sep; 38(7):2059-61. PubMed ID: 16979999
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of biliary complications in adult living-donor liver transplants performed at two busy transplant centers.
    Melcher ML; Pomposelli JJ; Verbesey JE; McTaggart RA; Freise CE; Ascher NL; Roberts JP; Pomfret EA
    Clin Transplant; 2010; 24(5):E137-44. PubMed ID: 20047615
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Obstruction of the common bile duct by a cystic duct cyst in the recipient after liver transplantation].
    Aghzadi R; Boillot O; Bernard O; Houssin D; Chapuis Y
    Ann Chir; 1990; 44(6):452-4. PubMed ID: 2221790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of low-dose valganciclovir in the prevention of cytomegalovirus disease in adult liver transplant recipients.
    Park JM; Lake KD; Arenas JD; Fontana RJ
    Liver Transpl; 2006 Jan; 12(1):112-6. PubMed ID: 16382458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term placement of subcutaneous Rüsch-type stents for double biliary stenosis in a living-donor liver transplant recipient.
    Adani GL; Baccarani U; Lorenzin D; Risaliti A; Como G; Gasparini D; Sponza M; Bresadola V; Bresadola F
    Cardiovasc Intervent Radiol; 2007; 30(2):339-41. PubMed ID: 16897265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.
    Rodriguez J; Casper K; Smallwood G; Stieber A; Fasola C; Lehneman J; Heffron T
    Liver Transpl; 2007 Oct; 13(10):1396-400. PubMed ID: 17902124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytomegalovirus infection does not increase the risk of vanishing bile duct syndrome after liver transplantation.
    van den Berg AP; Klompmaker IJ; Hepkema BG; Gouw AS; Haagsma EB; Lems SP; The TH; Slooff MJ
    Transpl Int; 1996; 9 Suppl 1():S171-3. PubMed ID: 8959818
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance of hepatic arterial collaterals in liver transplant recipients with biliary strictures.
    Viveiros A; Rehwald R; Vettori E; Finkenstedt A; Effenberger M; Schaefer B; Dorn L; Tilg H; Schneeberger S; Glodny B; Zoller H; Freund MC
    Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 27925689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibrosing cholestatic hepatitis-like syndrome in a hepatitis B virus and hepatitis C virus-negative renal transplant recipient: a case report with autopsy findings.
    Duseja A; Nada R; Kalra N; Acharya SK; Minz M; Joshi K; Chawla Y
    Trop Gastroenterol; 2003; 24(1):31-4. PubMed ID: 12974214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Balloon dilatation vs. balloon dilatation plus bile duct endoprostheses for treatment of anastomotic biliary strictures after liver transplantation.
    Zoepf T; Maldonado-Lopez EJ; Hilgard P; Malago M; Broelsch CE; Treichel U; Gerken G
    Liver Transpl; 2006 Jan; 12(1):88-94. PubMed ID: 16382450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The practical value of endoscopic retrograde cholangiography in biliary complications after liver transplantation].
    Wang GS; Lu MQ; Yang Y; Cai CJ; Zheng FP; Wang WD; Li H; Xu C; Yi SH; Yi HM; Chen GH
    Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(21):1453-5. PubMed ID: 17349166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG; Freeman R; Rohrer R
    Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patient and Graft Survival: Biliary Complications after Liver Transplantation.
    Senter-Zapata M; Khan AS; Subramanian T; Vachharajani N; Dageforde LA; Wellen JR; Shenoy S; Majella Doyle MB; Chapman WC
    J Am Coll Surg; 2018 Apr; 226(4):484-494. PubMed ID: 29360615
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial.
    Snydman DR; Werner BG; Dougherty NN; Griffith J; Rubin RH; Dienstag JL; Rohrer RH; Freeman R; Jenkins R; Lewis WD; Hammer S; O'Rourke E; Grady GF; Fawaz K; Kaplan MM; Hoffman MA; Katz AT; Doran M;
    Ann Intern Med; 1993 Nov; 119(10):984-91. PubMed ID: 8214995
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of biliary and duodenal complications of chronic pancreatitis.
    Vijungco JD; Prinz RA
    World J Surg; 2003 Nov; 27(11):1258-70. PubMed ID: 14534824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.